Skip to main navigation Skip to search Skip to main content

Lamivudinbehandling af en hepatitis Bs- antigen-positiv patient med reaktiv artritis

Translated title of the contribution: Lamivudine treatment of a HBs antigen positive man with reactive arthritis
  • Christian Borup
  • , Anders Siboni

Research output: Contribution to journal › Journal article › Research › peer-review

Abstract

A 46-year-old man who was HBs antigen positive since childhood had painful talocrural arthritis that was considered re-active to HBs antigen. Lamivudine treatment was started and HBV-DNA disappeared from the blood, and the joint swellings disappeared. HBe antibody disappeared after eight months. After one year and nine months lamivudine was discontinued, resulting in a flare of the hepatitis after 56 days: HBV-DNA rose to 40 million copies per ml and HBe antigen became positive. Lamivudine was reinstituted, resulting in normalization of ALAT and lowering of HBV-DNA under detection level.
Udgivelsesdato: Nov-24
Translated title of the contributionLamivudine treatment of a HBs antigen positive man with reactive arthritis
Original languageDanish
JournalUgeskrift for Læger
Volume170
Issue number48
Pages (from-to)3940-1
Number of pages1
ISSN0041-5782
Publication statusPublished - 24. Nov 2008

Keywords

  • Antiviral Agents
  • Arthritis, Reactive
  • DNA, Viral
  • Hepatitis B Antibodies
  • Hepatitis B Surface Antigens
  • Hepatitis B, Chronic
  • Humans
  • Lamivudine
  • Male
  • Middle Aged
  • Recurrence
  • Reverse Transcriptase Inhibitors
  • Treatment Outcome

Cite this